A Multicenter, Randomized Study to Evaluate the Efficacy and Safety of Mesalamine Suppositories 1 g at Bedtime and 500 mg Twice Daily in Patients with Active Mild-to-Moderate Ulcerative Proctitis

BACKGROUND: Ulcerative proctitis (UP) is a prevalent condition associated with increased morbidity and mortality. Topical mesalamine (5-aminosalicylic acid [5-ASA]) inhibits inflammatory processes in UP. METHODS: We evaluated effects of mesalamine 1-g suppository administered QHS compared with 500-m...

Descripción completa

Detalles Bibliográficos
Autor principal: Lamet, Mark
Formato: Texto
Lenguaje:English
Publicado: Springer US 2010
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3029674/
https://www.ncbi.nlm.nih.gov/pubmed/20676771
http://dx.doi.org/10.1007/s10620-010-1334-y

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3029674/
https://www.ncbi.nlm.nih.gov/pubmed/20676771
http://dx.doi.org/10.1007/s10620-010-1334-y

Ejemplares similares